Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 5

Big endothelin-1 as a clinical marker for ventricular tachyarrhythmias in patients with post-infarction left ventricular aneurysm

Pages
256–261
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NT-proBNP and left ventricular ejection fraction of ≤35% were demonstrated to be independently predictive of cardiovascular mortality and all-cause mortality.Conclusion: Increased big ET-1 concentration in PI-LVA patients is a valuable independent predictor for the prevalence of ventricular tachyarrhythmias and VT/VF attacks during follow-up after PI-LVA treatment. (Anatol J Cardiol 2019; 22: 256-61)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ventricular tachyarrhythmia is the leading cause of death in post-infarction patients.
📊
Key Findings & Data:Big endothelin-1 (ET-1) is a potent vasoconstrictor peptide and plays a role in ventricular tachyarrhythmia development.
💡
Conclusion & Impact:NT-proBNP and left ventricular ejection fraction of ≤35% were demonstrated to be independently predictive of cardiovascular mortality and all-cause mortality.Conclusion: Increased big ET-1 concentration in PI-LVA patients is a valuable independent predictor for the prevalence of ventricular tachyarrhythmias and VT/VF attacks during follow-up after PI-LVA treatment. (Anatol J Cardiol 2019; 22: 256-61)
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Ventricular tachyarrhythmia is the leading cause of death in post-infarction patients. Big endothelin-1 (ET-1) is a potent vasoconstrictor peptide and plays a role in ventricular tachyarrhythmia development. The aim of this study was to investigate the association between the serum concentration of big ET-1 and ventricular tachyarrhythmia in post-infarction left ventricular aneurysm (PI-LVA) patients.Methods: A total of 222 consecutive PI-LVA patients who had received medical therapy were enrolled in the study. There were 43 (19%) patients who had ventricular tachycardia/ventricular fibrillation (VT/VF) at the time of admission. The clinical characteristics were observed and the plasma big ET-1 level was measured. Associations between big ET-1 and the presence of VT/VF were assessed. Patients were followed up to check for outcomes related to cardiovascular mortality, VT/VF attack, and all-cause mortality.Results: The median concentration of big ET-1 was 0.635 pg/mL. Patients with big ET-1 concentrations above the median were more likely to have higher risk clinical features. There was a positive correlation between the level of big ET-1 with VT/VF attack (r=0.354, p<0.001). In the multiple logistic regression analysis, big ET-1 (OR=4.06, 95% CI: 1.77-9.28, p<0.001) appeared as an independent predictive factor for the presence of VT/ VF. Multiple Cox regression analysis suggested that big ET-1 concentration was independently predictive of VT/VF attack (OR=2.5, 95% CI 1.4–4.5, p<0.001). NT-proBNP and left ventricular ejection fraction of ≤35% were demonstrated to be independently predictive of cardiovascular mortality and all-cause mortality.Conclusion: Increased big ET-1 concentration in PI-LVA patients is a valuable independent predictor for the prevalence of ventricular tachyarrhythmias and VT/VF attacks during follow-up after PI-LVA treatment. (Anatol J Cardiol 2019; 22: 256-61)

🔖

Cite This Article

NING, X., YANG, Z., YE, X., Sİ, Y., WANG, F., ZHANG, X., ZHANG, S. (2019). Big endothelin-1 as a clinical marker for ventricular tachyarrhythmias in patients with post-infarction left ventricular aneurysm. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 5, 256–261. https://ajindex.com/articles/365749

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ning X, Ye X, Si Y, Yang Z, Zhao Y, Sun Q, et al. Prevalence and prognosis of ventricular tachycardia/ventricular fibrillation in patients with post-infarction left ventricular aneurysm: Analysis of 575 cases. J Electrocardiol 2018; 51: 742-6. 2. van Kimmenade RR, Januzzi JL Jr. Emerging biomarkers in heart failure. Clin Chem 2012; 58: 127-38
  2. Szücs A, Keltai K, Zima E, Vágó H, Soós P, Róka A, et al. Effects of implantable cardioverter defibrillator implantation and shock application on serum endothelin-1 and big-endothelin levels. Clin Sci (Lond) 2002; 103 Suppl 48: 233S-6S
  3. Szabó T, Gellér L, Merkely B, Selmeci L, Juhász-Nagy A, Solti F. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect? Life Sci 2000; 66: 2527-41
  4. Vágó H, Soós P, Zima E, Gellér L, Keltai K, Róka A, et al. Changes of endothelin-1 and big endothelin-1 levels and action potential duration during myocardial ischemia-reperfusion in dogs with and without ventricular fibrillation. J Cardiovasc Pharmacol 2004; 44 Suppl 1: S376-9
  5. Watts SW, Thakali K, Smark C, Rondelli C, Fink GD. Big ET-1 processing into vasoactive peptides in arteries and veins. Vascul Pharmacol 2007; 47: 302-12
  6. Kolettis TM, Barton M, Langleben D, Matsumura Y. Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev 2013; 21: 249-56
  7. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004; 95: 754-63
  8. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014; 63: 141-9
  9. Wilbert-Lampen U, Nickel T, Leistner D, Güthlin D, Matis T, Völker C, et al. Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during world cup soccer 2006. J Am Coll Cardiol 2010; 55: 637-42
  10. Tawa M, Yamamoto S, Ohkita M, Matsumura Y. Endothelin-1 and norepinephrine overflow from cardiac sympathetic nerve endings in myocardial ischemia. Cardiol Res Pract 2012; 2012: 789071
  11. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004; 95: 76-83
  12. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, et al. Nerve sprouting and sudden cardiac death. Circ Res 2000; 86: 816-21
  13. Fukuda K, Kanazawa